menu close
www.color.com
Color-Logo

Color Genomics Stock

Company Profile:

Color Genomics provides physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Sign up for SecondMarket® to view the market and buy or sell Color Genomics Stock
Buy + Sell

Color Genomics Stock Price Chart

The below graph shows the estimated historical Color Genomics stock price as of last month, known as the Tape D® price. The Color Genomics Tape D® price is based on market activity, publicly-sourced valuation data, and other proprietary information. Create an account to see the current estimated Color Genomics price per share.

24 Months 12 Months 6 Months
Color Genomics Stock Price Per Share

Color Genomics Funding

Sign up to gain insights into Color Genomics funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Oct 26, 2021 Series E 100.00M
Price
Valuation
Dec 17, 2020 Series D 89.52M
Price
Valuation
Dec 17, 2020 Series D 37.70M
Price
Valuation
Nov 14, 2017 Series C 37.45M
Price
Valuation
Aug 03, 2017 Series C 51.99M
Price
Valuation
Aug 16, 2016 Series B 38.55M
Price
Valuation
Feb 11, 2015 Series A 22.57M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

Leverage Your Equity to Help Achieve More.

Color Genomics Management Team

  • COO

    Tony Wang

  • Co-Founder, President, CEO, Director

    Othman Laraki

  • Founding Engineer

    Nish Bhat

  • Co-founder, Director

    Gil Elad

  • Chief Marketing Officer

    Katie Stanton

  • Director

    Susan L. Wagner

  • Co-Founder, Chief Scientific Officer

    Taylor Sittler

  • Chief Medical Officer

    Jill Hagenkord

  • Director

    Hemant Taneja

Color Genomics Major Investors

  • CRV

  • General Catalyst Partners LLC

  • T. Rowe Price Associates, Inc.

  • Emerson Collective LLC

  • 8VC

  • Viking Global Investors

  • Khosla Ventures LLC

  • Kindred Ventures

Learn More About Color Genomics Stock

Buy Color Genomics Stock
01

Color Genomics stock does not trade on public stock exchanges. Color Genomics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Color Genomics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Color Genomics Stock
02

Color Genomics Stock does not trade on public stock exchanges. In order to sell Color Genomics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Color Genomics Stock Price
03

Nasdaq Private Market estimates that Color Genomics price per share was $36.06 last month. This Color Genomics share value estimate (known as the Tape D™ price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With Tape D premium for investors, you can get visibility into the Color Genomics share price today and the factors driving Color Genomics valuation estimates. Learn more about premium data here.

Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price

Color Genomics Stock Ticker Symbol
04

There is no ticker symbol for Color Genomics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Color Genomics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Color Genomics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Color Genomics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Color Genomics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Color Genomics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Color Genomics IPO
08

Color Genomics is a private company and has not had an IPO. There is currently no Color Genomics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Color Genomics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Color Genomics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Inariag-Logo

Inari Agriculture

Uses AI-powered predictive design and gene editing to create sustainable, nature-positive seeds for a more efficient food system.

Medable Inc.-Logo

Medable

Global cloud platform for decentralized clinical trials.

Solugen-Logo

Solugen

Manufactures biobased solutions that replace chemicals traditionally made using petroleum or natural gas.

Source: Nasdaq Private Market Tape D®